Hamson Pharmaceuticals And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 342574.43%
- Profit Growth -18088.66%
- Ebitda -18002.62%
- Net Worth -1108.57%
- Total Assets 976.51%
About Hamson Pharmaceuticals And Chemicals
Hamson Pharmaceuticals And Chemicals Private Limited (HPACPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2018 (Six years and eight months 0 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Joshi and Smita Joshi serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304PN2018PTC177103
-
Company No.
177103
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Hamson Pharmaceuticals And Chemicals Private Limited offer?
Hamson Pharmaceuticals And Chemicals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Flavours & Aromatics, Food Enzymes, Bird Food, Poultry & Animal Food, Feed Additives, Laboratory Chemicals, Bio Chemicals, Pharmaceutical Excipients, Weight Gain Nutrition.
Who are the key members and board of directors at Hamson Pharmaceuticals And Chemicals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Smita Joshi | Director | 08-Jun-2018 | Current |
Narendra Joshi | Director | 08-Jun-2018 | Current |
Financial Performance of Hamson Pharmaceuticals And Chemicals.
Hamson Pharmaceuticals And Chemicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 342574.43% increase. The company also saw a substantial fall in profitability, with a 18088.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1108.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hamson Pharmaceuticals And Chemicals?
Unlock access to Hamson Pharmaceuticals And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hamson Pharmaceuticals And Chemicals?
Unlock and access historical data on people associated with Hamson Pharmaceuticals And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hamson Pharmaceuticals And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hamson Pharmaceuticals And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.